Sio Gene Therapies Inc. (SIOX): Ready for an explosive trading day – Invest Chronicle

Sio Gene Therapies Inc. (SIOX): Ready for an explosive trading day

Let’s start up with the current stock price of Sio Gene Therapies Inc. (SIOX), which is $0.26 to be very precise. The Stock rose vividly during the last session to $0.27 after opening rate of $0.26 while the lowest price it went was recorded $0.25 before closing at $0.25.Recently in News on April 27, 2022, Sio Gene Therapies Provides Corporate Update. -Company Announces Termination of Licensing Agreement for GM1 and GM2 Gene Therapies with the University of Massachusetts-Company has engaged SVB Securities to advise it on a range of strategic alternatives to maximize stockholder value-Company had cash and cash equivalents of approximately $64 million at March 31, 2022; license termination and related headcount reduction lowers operating expenses significantly. You can read further details here

Sio Gene Therapies Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5250 on 01/03/22, with the lowest value was $0.2300 for the same time period, recorded on 05/12/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Sio Gene Therapies Inc. (SIOX) full year performance was -90.18%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sio Gene Therapies Inc. shares are logging -91.19% during the 52-week period from high price, and 3.92% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $2.95.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1560001 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Sio Gene Therapies Inc. (SIOX) recorded performance in the market was -80.60%, having the revenues showcasing -68.69% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 18.30M, as it employees total of 42 workers.

Sio Gene Therapies Inc. (SIOX) in the eye of market guru’s

According to the data provided on, the moving average of the company in the 100-day period was set at 0.7928, with a change in the price was noted -1.11. In a similar fashion, Sio Gene Therapies Inc. posted a movement of -80.95% for the period of last 100 days, recording 570,146 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SIOX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Sio Gene Therapies Inc. (SIOX): Stocks Technical analysis and Trends

Raw Stochastic average of Sio Gene Therapies Inc. in the period of last 50 days is set at 5.96%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.74%. In the last 20 days, the company’s Stochastic %K was 3.81% and its Stochastic %D was recorded 3.68%.

If we look into the earlier routines of Sio Gene Therapies Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -80.60%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -87.29%, alongside a downfall of -90.18% for the period of the last 12 months. The shares increased approximately by -18.73% in the 7-day charts and went up by -60.64% in the period of the last 30 days. Common stock shares were lifted by -68.69% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts